124 related articles for article (PubMed ID: 2463110)
1. [Interleukin and interferon--hope or disappointment?].
Vanĕcek K
Cesk Pediatr; 1988 Oct; 43(10):607-9. PubMed ID: 2463110
[No Abstract] [Full Text] [Related]
2. Biological response modifiers. Interferons, interleukins, and transfer factor.
Kirkpatrick CH
Ann Allergy; 1989 Mar; 62(3):170-6. PubMed ID: 2466425
[TBL] [Abstract][Full Text] [Related]
3. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
4. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part II: radiobiological and immunologic strategies].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Jun; 180(6):331-9. PubMed ID: 15175867
[TBL] [Abstract][Full Text] [Related]
5. [Systemic and regional administration of cytokines in oncology].
Lejeune F
Rev Med Suisse Romande; 1993 Jan; 113(1):11-2. PubMed ID: 7679521
[No Abstract] [Full Text] [Related]
6. Immunotherapy.
James G
Rev Invest Clin; 1990 Jul; 42 Suppl():22-7. PubMed ID: 19256128
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in dermatology.
Holman DM; Kalaaji AN
J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
[TBL] [Abstract][Full Text] [Related]
8. [Interferon in cancer--belief, hope and reality].
Strander H; Einhorn S
Lakartidningen; 1980 Aug; 77(32-33):2673-5. PubMed ID: 6161282
[No Abstract] [Full Text] [Related]
9. Interferon: reason for hope.
Warren B
Can Nurse; 1983 Feb; 79(2):15-6. PubMed ID: 6186360
[No Abstract] [Full Text] [Related]
10. Cytokines in the treatment of malignancies.
Jákó J; Arató G; Domján G; Hasitz A; Holló G; Petó M; Stélich G; Schopper J
Acta Med Hung; 1994; 50(3-4):257-73. PubMed ID: 8587839
[TBL] [Abstract][Full Text] [Related]
11. Biological approaches to cancer therapy.
Thomas H; Sikora K
J Int Med Res; 1989; 17(3):191-204. PubMed ID: 2475373
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the management of biotherapy-related side effects: fatigue.
Piper BF; Rieger PT; Brophy L; Haeuber D; Hood LE; Lyver A; Sharp E
Oncol Nurs Forum; 1989; 16(6 Suppl):27-34. PubMed ID: 2480583
[TBL] [Abstract][Full Text] [Related]
13. [The introduction of interleukins to the world].
Pelet B; Gautier E
Rev Med Suisse Romande; 1991 Oct; 111(10):879-83. PubMed ID: 1719599
[No Abstract] [Full Text] [Related]
14. Molecular approaches to cancer immunotherapy.
Forni G; Cavallo F; Consalvo M; Allione A; Dellabona P; Casorati G; Giovarelli M
Cytokines Mol Ther; 1995 Dec; 1(4):225-48. PubMed ID: 9384678
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunomodulation.
Galbraith GM
Dermatol Clin; 1988 Oct; 6(4):561-8. PubMed ID: 2465856
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and cancer.
Malik S; Waxman J
BMJ; 1992 Aug; 305(6848):265-7. PubMed ID: 1382767
[No Abstract] [Full Text] [Related]
17. Genetic strategies for brain tumor therapy.
Lawler SE; Peruzzi PP; Chiocca EA
Cancer Gene Ther; 2006 Mar; 13(3):225-33. PubMed ID: 16138122
[TBL] [Abstract][Full Text] [Related]
18. Interferon may enhance the activity of interleukin-2.
Oncology (Williston Park); 1988 Jul; 2(7):11. PubMed ID: 2484280
[No Abstract] [Full Text] [Related]
19. [Antitumor immunotherapy].
Błoński JZ; Warzocha K
Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
